Catalyst Wire Dossier Catalyst Wire Dossier

GSK's MMR vaccine (209762)

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK's MMR vaccine (209762), covering 2011-11-04 to 2011-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age [Phase 2]

See pricing